Amber

formerly Amber Bio

Amber Bio

San Francisco, United States · Founded 2023 · $26.0M raised

Employees
11–50
Founded
2023
Business Model
B2B
Website
amber.bio
Total Funding
$26.0M
Last Round
$26.0M SeedAug 2023
Rounds
1

About

Amber Bio is a San Francisco biotechnology company developing an RNA-editing platform that enables programmable, multi-kilobase edits to RNA in a single step. Spun out of research from the Broad Institute and UC Berkeley, its CRISPR-mediated trans-splicing technology rewrites thousands of bases without cutting DNA, making it suited to genetic diseases with high allelic diversity where conventional gene editing falls short. The company launched in 2023 with a $26 million seed round co-led by Playground Global and Andreessen Horowitz Bio + Health.

Summary

Amber is an Artificial Intelligence company based in San Francisco, United States, founded in 2023. It has raised $26.0M in total across 1 round, most recently a $26.0M Seed round in Aug 2023. Investors include Playground Global, Andreessen Horowitz and Hummingbird Ventures.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed RoundAug 2023
$26.0M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Amber on Indexed.vc
<a href="https://indexed.vc/companies/amber"><img src="https://indexed.vc/api/badge/company/amber" alt="Amber on Indexed.vc" width="260" height="76" /></a>